Welcome to the Inaugural Model-Informed Drug Development Summit
Accelerate Smarter Drug Development with MIDD
Model-Informed Drug Development (MIDD) has rapidly evolved, from a supportive tool to a core driver of decision-making across the entire drug development lifecycle. Backed by the draft ICH M15 guidance and compelling studies showing MIDD can save up to 10 months and $5 million per program, the value is no longer theoretical, it's transformational.
Join us at the Model-Informed Drug Development Summit, a 3-day event featuring 20+ real-world case studies that showcase how MIDD is reshaping the industry.
Discover how to:
- Boost efficiency and reduce costs
- Mitigate risk across development stages
- Enhance product labeling for real-world impact
Whether you're optimizing existing MIDD strategies or evaluating its potential, join other pharmacometricians, clinical pharmacologists, and PKPD modelers to explore how MIDD can shift the benefit-risk balance in your favour.
Ready to unlock the full potential of MIDD? Join the conversation. Shape the future.
World-Class Speaker Faculty Includes
Prathap Nagaraja Shastri
Scientific Director & Group Leader, Clinical Pharmacology & Pharmacometrics
Johnson and Johnson
Our Partner
*Partnership Opportunities Closing Soon!
Ready to showcase your modeling and simulation expertise at the forefront of MIDD innovation? Connect with decision-makers who need your solutions, partner with us today.
Companies Attending This Year
"Model-informed drug development is a powerful way to bring clarity and efficiency to the complex process of drug development. I’m looking forward to engaging with others in this event to share insights, deepen our collective understanding, and ultimately help bring impactful therapies to patients faster."
Mahdiar Sadeghi,
Senior Scientist, Denali Therapeutics